⚠ Scores are AI-generated estimates for informational purposes only — not investment advice. Data may be inaccurate or outdated. Do not make financial decisions based on this site. Full legal disclaimer →
⚠ Scores are AI-generated estimates for informational purposes only — not investment advice. Data may be inaccurate or outdated. Do not make financial decisions based on this site. Full legal disclaimer →
AI Exposure Analysis
Other · Private · Disruption threat: MEDIUM
Duke is a leading research university with significant AI investment through initiatives like the Rhodes Information Initiative and strong AI/ML faculty across engineering, medicine, and policy. Its medical center and research enterprise are increasingly AI-integrated, though core revenue remains tuition and grants rather than direct AI commercialization.
Duke University is a top-tier private research institution with significant academic, clinical, and policy influence. With an overall AI score of 62/100, Duke occupies a strong position among educational institutions, driven by deep research integration rather than direct AI commercialization. Its Rhodes Information Initiative and cross-disciplinary AI/ML faculty anchor a robust institutional commitment to artificial intelligence. R&D AI Investment leads all dimensions at 80/100, reflecting Duke's substantial publication output and funded research across medicine, engineering, and public policy. Product AI Integration and Internal AI Use both score 65/100, supported by AI-enhanced clinical decision support at Duke Health and administrative tools covering academic advising, grading, and analytics. AI Infrastructure at 70/100 underscores meaningful technical capacity, while Revenue from AI scores a modest 35/100, consistent with an institution whose primary income remains tuition and research grants rather than AI product sales. The medium disruption threat reflects a dual dynamic. Duke both contributes to AI advancement and faces displacement risk in traditional educational delivery, particularly in instruction and advising functions increasingly addressable by AI tools. The clearest opportunity lies in Duke Health's clinical AI pipeline, where proprietary patient data and research infrastructure could support translational partnerships or licensing arrangements that convert R&D strength into measurable revenue diversification.
Full interactive analysis at RankVis.io